Hypoxia-induced intrauterine growth retardation: effects on pulmonary development and surfactant protein

L Gortner1, A Hilgendorff, T Bähner

  • 1Department of Pediatrics and Neonatology, University of Saarland, Homburg/Saar, Germany. kilgor@uniklinik-saarland.de

Insights

Hypoxia-induced intrauterine growth restriction (IUGR) in mice significantly reduced surfactant protein gene expression, impacting lung development. This finding suggests a link between altered surfactant production and pulmonary issues in preterm infants with IUGR.

Area of Science:

  • Perinatal medicine
  • Developmental biology
  • Pulmonary research

Background:

  • Intrauterine growth retardation (IUGR) in preterm infants increases the risk of pulmonary disorders like bronchopulmonary dysplasia (BPD).
  • A reproducible animal model using hypoxia was established to study IUGR's effects on fetal lung development.

Purpose of the Study:

  • To investigate the impact of IUGR, induced by maternal hypoxia, on pulmonary development and maturation in a mouse model.
  • To assess changes in somatic growth and surfactant protein gene expression.

Main Methods:

  • Mice were exposed to hypoxia (FiO2 0.10) from day 14 to 17.5 of gestation, with a normoxic control group.
  • Somatic growth parameters were measured, and histomorphometric analyses of lung tissue were performed.
  • Quantitative rt-PCR was used to determine the mRNA expression of surfactant proteins (SP-A, -B, -C, -D).

Main Results:

  • Hypoxic fetuses exhibited significantly reduced birth weight, body length, and fronto-occipital diameter compared to controls.
  • Histomorphometric analysis showed no significant differences in lung tissue structure between groups.
  • mRNA expression of SP-A, SP-B, and SP-C was significantly decreased in hypoxic fetuses, while SP-D expression remained unchanged.

Conclusions:

  • Maternal hypoxia during late gestation induces IUGR in preterm mice, altering the developing surfactant system.
  • Reduced surfactant protein gene expression is a key finding, potentially contributing to pulmonary complications in IUGR infants.
  • This model highlights the critical role of the surfactant system in IUGR-related pulmonary disorders.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...